Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system

Drug Development and Industrial Pharmacy

Volumn 33, Issue 8, 2007, Pages 812-823

  Mehramizi, Ali ^a,b   Alijani, Behnaz ^a   Pourfarzib, Mojgan ^c   Dorkoosh, Farid A ^d   Tehrani, Morteza Rafiee ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Tehran Chemie Pharmaceutical Co   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Differential scanning calorimetery (DSC); Glipizide; Osmotic pump; Polyvinylpyrrolidone (PVP); Solid dispersions; X ray diffraction analysis (XRD)

Indexed keywords

DODECYL SULFATE SODIUM; GLIPIZIDE; LACTOSE; MAGNESIUM STEARATE; MEGLUMINE; POVIDONE; STARCH;

ARTICLE; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; OSMOTIC PUMP; PHYSICAL CHEMISTRY; SCANNING ELECTROCHEMICAL MICROSCOPY; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GLIPIZIDE; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; MICROSCOPY, ELECTRON, SCANNING; OSMOSIS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 34548321483     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601128753     Document Type: Article

References (32)

1. Chiou, W. L., & Riegelman, S. (1969). Preparation and dissolution characteristics of several fast release solid dispersion of griseofulvin. Journal Pharmaceutical Sciences, 58, 1505-1509.
2. Chiou, W. L., & Riegelman, S. (1971). Pharmaceutical application of solid dispersion systems. Journal Pharmaceutical Sciences, 60, 1281-1302.
3. Geerke, J. H. (1997). Method and apparatus for forming dispenser delivery ports. US patent 5,658,474.
4. Herbig, S. M., Cardinal, J. R., Korsmeyer, R. W., & Smith, K. L. (1995). Asymmetric membrane tablet coating for osmotic drug delivery. Journal of Controlled Release, 35, 127-136.
5. Higuchi, T., & Connors, K. A. (1965). Phase-solubility techniques. Advances in analytical Chemistry and Instrumentation, 4, 212-217.
6. Jensen, J. L., Appel, L. E., Clair, J. H., & Zentner, G. M. (1995). Variables that affect the mechanism of drug release from osmotic pumps coated with acrylate/methacrylate copolymer latexes., Journal Pharmaceutical Sciences, 84, 530-533.
7. Kharmnna, S. C. (1991). Therapeutic system for sparingly soluble active ingredients. US patent 4,992,278.
8. Kuczynski, A. L., Ayer, A. D., & Wong, P. S. (1997). Dosage form for administering oral hypoglycemic glipizide. US patent 5,545,413.
9. Margarit, M. V., Marin, M. T., & Contreras, M. D. (2001). Solubility of solid dispersion of pizotifen malate and povidone. Drug Development and Industrial Pharmacy, 27, 517-522.
10. Martinez-Oharriz, M. C., Rodriguez-Espinosa, C., Martin, C., Goni, M. M., Tros-Iiarduya, M. C., & Sanchez, M. (2002). Solid dispersion of diflunisal-PVP: polymorphic and amorphous states of the drug. . Drug Development and Industrial Pharmacy, 28, 717-725.
11. McClelland, G. A., Sulton, S. C., Engle, K., & Zentner, G. M. (1991). The solubility-modulated osmotic pump: invitro/invivo release of diltiazem hydrochloride. Pharmaceutical Research, 8, 88-92.
12. Mura, P., Faucci, M. T., & Bettinetti, G. P. (2001). The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl -β-cyclodextrin. European Journal of Pharmaceutical Sciences, 13, 187-194.
13. 7m-ß- CD. Pharmaceutical Research, 15, 1562-1568.
14. 7m-ß-CD. Pharmaceutical Research, 16, 549-554.
15. 7m-ß- CD as both a solubilizing and an osmotic pump agent. Journal of Controlled Release, 58, 29-38.
16. Ouyang, D., Nie, S., li, W., Guo, H., liu, H., & Pan, W. (2005). Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets. Journal of Pharmacy and Pharmacology, 57, 817-820.
17. Raymond, G. G., & Born, J. L. (1986). An updated pK listing of a medicinal compounds, Drug Intell. Clin. Pharm. 20, 683-686.
18. Ruan, L. P., Yu, B. Y., Fu, G. M., & Zhu, D. N. (2005). Improving the solubility of ampelopsin by solid dispersion and inclusion complexes. Journal of Pharmaceutical and Biomedical Analysis, 38, 457-464.
19. Simonelli, A. P., Metha, S. C., & Higuchi, W. I. (1994). Dissolution rates of high energy polyvinylpyrrolidone / vinylacetate copolymer (PVP/VA). STP Pharma Sciences, 4, 122-127.
20. Swanson, D. R., Barclay, B. L., Wong, P. S. L., & Theeuwes, F. (1987). Nifedipine gastrointestinal therapeutic system. The American journal of medicine, 83 (suppl. 6B), 3-9.
21. Theeuwes, F. (1975). Elementary osmotic pump. Journal Pharmaceutical Sciences, 64, 1987-1991.
22. Theeuwes, F. (1978). Osmotic system for delivering selected beneficial agents having varying degrees of solubility. US patent 4,111,201.
23. Theeuwes, F., & Higuchi, T. (1972). Osmotic dispensing device for releasing beneficial agent. US patent 3,845,770.
24. Theeuwes, F. Swanson, D., Wong, P., Bonsen, P., Place, V., Heimlich, K., & Kwan, K. C., (1983). Elementary osmotic pump for indomethacin. Journal Pharmaceutical Sciences, 72, 253-258.
25. Thombre, A. J., Cardinal, J. R., Denoto, A. R., & Gibbes, D. C. (1999). Asymmetric membrane capsules for osmotic drug delivery: II, in vitro and in vivo drug release performance. Journal of Controlled Release, 57, 65-72.
26. Thombre, A. G., Denoto, A. R., & Gibbes, D. C. (1999). Delivery of glipizide from asymmetric membrane capsule using encapsulated excipients. Journal of Controlled Release, 60, 281-285.
27. Vadnere, M. K. (1998). Thermal analysis of drugs and drug products, In Encyclopedia of Pharmaceutical Technology, Vol. 15, Swarbrick, J., Ed.; Marcel Dekker, Inc.: New York, 1-79.
28. Vadnere, M. K. (2002). Copercipitates and melts. In Encyclopedia of Pharmaceutical Technology, Vol. 1, Swarbrick, J., Ed.; Marcel Dekker, Inc.: New York, pp. 641-648.
29. Verma, R. K., & Garg, S. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glipizide. European Journal of Pharmaceutics Biopharmaceutics, 57, 513-525.
30. Verma, R. K., Krishna, D. M., & Garg, S. (2002). Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of Controlled Release, 79, 7-27.
31. Verma, R. K., Mishra, B., & Garg, S. (2000). Osmotically controlled oral drug delivery. Drug Development and Industrial Pharmacy, 26, 695-708.
32. Yagi, N., Terashima, T., Kenmotsu, H., Sekikawa, H., & Takada, M. (1996). Dissolution behavior of probucol from solid Dispersion systems of probucol polyvinylpyrrolidone. Chemical Pharmaceutical Bulletin, 44, 241-244.